1. Home
  2. RAPP vs EYE Comparison

RAPP vs EYE Comparison

Compare RAPP & EYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$41.85

Market Cap

1.8B

Sector

N/A

ML Signal

HOLD

Logo National Vision Holdings Inc.

EYE

National Vision Holdings Inc.

HOLD

Current Price

$19.90

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAPP
EYE
Founded
2022
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Ophthalmic Goods
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.8B
IPO Year
2024
2017

Fundamental Metrics

Financial Performance
Metric
RAPP
EYE
Price
$41.85
$19.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
9
Target Price
$48.50
$31.22
AVG Volume (30 Days)
431.1K
2.1M
Earning Date
05-08-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
24.34
202.78
EPS
N/A
0.38
Revenue
N/A
$1,987,488,000.00
Revenue This Year
N/A
$5.56
Revenue Next Year
N/A
$6.58
P/E Ratio
N/A
$50.71
Revenue Growth
N/A
9.00
52 Week Low
$13.64
$14.75
52 Week High
$43.76
$30.02

Technical Indicators

Market Signals
Indicator
RAPP
EYE
Relative Strength Index (RSI) 59.76 61.49
Support Level $33.54 $14.84
Resistance Level $43.76 $20.43
Average True Range (ATR) 2.88 0.85
MACD 0.15 0.19
Stochastic Oscillator 66.30 90.00

Price Performance

Historical Comparison
RAPP
EYE

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biotechnology company dedicated to the discovery and development of small-molecule precision medicines for patients with neurological or psychiatric disorders. The company's portfolio of programs from its RAP technology platform includes RAP-219, an investigational small molecule being developed as a therapy for focal onset seizures, primary generalized tonic-clonic seizures, and bipolar mania. Additionally, it has two discovery-stage nicotinic acetylcholine receptor (nAChR) programs stemming from its RAP technology platform: one being developed for the treatment of chronic pain, and the second, being developed for the treatment of hearing disorders. Geographically, the company operates in the United States.

About EYE National Vision Holdings Inc.

National Vision Holdings Inc. is an optical retailer in the United States. Its product portfolio includes eyeglasses, sunglasses, contact lenses, accessories, and other related products. The company operates through a single operating segment. The Owned and Host segment includes the company-owned brands America's Best and Eyeglass World. In America's Best stores, vision care services are provided by optometrists or by independent professional corporations. The Host segment consists of Military and Fred Meyer locations, where eye exams are provided by independent optometrists.

Share on Social Networks: